ATE554385T1 - Verfahren zur selektiven untersuchung von adiponectin-multimeren - Google Patents

Verfahren zur selektiven untersuchung von adiponectin-multimeren

Info

Publication number
ATE554385T1
ATE554385T1 AT09004308T AT09004308T ATE554385T1 AT E554385 T1 ATE554385 T1 AT E554385T1 AT 09004308 T AT09004308 T AT 09004308T AT 09004308 T AT09004308 T AT 09004308T AT E554385 T1 ATE554385 T1 AT E554385T1
Authority
AT
Austria
Prior art keywords
adiponectin
electrophoresed
kda
sds
exhibits
Prior art date
Application number
AT09004308T
Other languages
English (en)
Inventor
Hiroyuki Ebinuma
Hirokazu Yago
Yuka Akimoto
Osamu Myazaki
Takashi Kadowaki
Toshimasa Yamauchi
Kazuo Hara
Original Assignee
Sekisui Medical Co Ltd
Toudai Tlo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Medical Co Ltd, Toudai Tlo Ltd filed Critical Sekisui Medical Co Ltd
Application granted granted Critical
Publication of ATE554385T1 publication Critical patent/ATE554385T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT09004308T 2003-10-15 2004-10-15 Verfahren zur selektiven untersuchung von adiponectin-multimeren ATE554385T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003354930 2003-10-15

Publications (1)

Publication Number Publication Date
ATE554385T1 true ATE554385T1 (de) 2012-05-15

Family

ID=34463157

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04792477T ATE439590T1 (de) 2003-10-15 2004-10-15 Verfahren zum selektiven testen von adiponectinmultimeren
AT09004308T ATE554385T1 (de) 2003-10-15 2004-10-15 Verfahren zur selektiven untersuchung von adiponectin-multimeren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT04792477T ATE439590T1 (de) 2003-10-15 2004-10-15 Verfahren zum selektiven testen von adiponectinmultimeren

Country Status (12)

Country Link
US (2) US7608405B2 (de)
EP (2) EP2071333B1 (de)
JP (1) JP4677545B2 (de)
KR (1) KR101206338B1 (de)
CN (1) CN1867828B (de)
AT (2) ATE439590T1 (de)
AU (1) AU2004282754B9 (de)
CA (1) CA2542824C (de)
DE (1) DE602004022575D1 (de)
ES (2) ES2329582T3 (de)
MX (1) MXPA06004235A (de)
WO (1) WO2005038457A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
CN1882363A (zh) * 2003-11-07 2006-12-20 默克公司 鉴别胰岛素敏化剂治疗应答者的方法
EP1904082B1 (de) * 2005-07-21 2010-05-19 BioVendor Laboratory Medicine, Inc. VERFAHREN ZUR BESTIMMUNG DER KONZENTRATION DER ADIPOZYTAREN FORM DES FATTY ACID BINDUNG PROTEIN (A-FABP, FABP4, aP2)
KR20140087058A (ko) 2005-11-30 2014-07-08 애브비 인코포레이티드 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
AU2006319358B2 (en) 2005-11-30 2012-01-19 AbbVie Deutschland GmbH & Co. KG Anti-Abeta globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
ES2699627T3 (es) 2007-11-30 2019-02-12 Siemens Healthcare Diagnostics Inc Fragmentos de receptores de adiponectina y métodos de uso
DK2857525T3 (da) 2008-02-29 2019-07-22 Univ Oxford Innovation Ltd Fremgangsmåde til bestemmelse af en passende dosis statin
JP5398697B2 (ja) * 2008-02-29 2014-01-29 積水メディカル株式会社 高分子量アディポネクチンの測定方法
JP2011521248A (ja) * 2008-05-20 2011-07-21 エフ．ホフマン−ラ ロシュ アーゲー メタボリックシンドロームを有する患者及び有しない患者のリスク分析
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
JP2012502290A (ja) * 2008-09-11 2012-01-26 エフ．ホフマン−ラ ロシュ アーゲー メタボリックシンドロームを有する患者におけるナトリウム利尿ペプチドおよびアディポネクチン
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
EP2353015A1 (de) * 2008-11-10 2011-08-10 F. Hoffmann-La Roche AG Relevanz der darmadipozytenfunktion bei typ-1-diabetes
EP2211182A1 (de) 2009-01-16 2010-07-28 Roche Diagnostics GmbH Verfahren zur Bewertung des Schweregrades einer Leberzirrhose
EP3444611A1 (de) 2009-04-23 2019-02-20 Siemens Healthcare Diagnostics Inc. Monomere und dimere formen von adiponectin-rezeptor-fragmenten sowie und verfahren zur verwendung davon
AU2010245543B2 (en) 2009-05-07 2015-08-13 Otsuka Pharmaceutical Co., Ltd. Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
CA2796339C (en) 2010-04-15 2020-03-31 Abbott Laboratories Amyloid-beta binding proteins
JP5685777B2 (ja) * 2010-04-28 2015-03-18 株式会社エヌビィー健康研究所 バーチャルウエスタンブロッティングシステム
CN102939541B (zh) 2010-06-15 2015-12-02 弗·哈夫曼-拉罗切有限公司 手术后急性肾损伤的预测和识别
JP6147665B2 (ja) 2010-08-14 2017-06-14 アッヴィ・インコーポレイテッド アミロイドベータ結合タンパク質
EP2392927A1 (de) 2011-03-11 2011-12-07 F. Hoffmann-La Roche AG Diagnose von Stoffwechselstörungen in HIV-infizierten Patienten
EP2385372A1 (de) 2011-06-21 2011-11-09 Roche Diagnostics GmbH Nierenerkrankung in einer normal und nicht normal verlaufenden Schwangerschaft
EP2568291A1 (de) 2011-09-07 2013-03-13 Roche Diagnostics GmbH L-FABP-basierte Diagnose eines Nierentraumas nach einem akuten Ereignis oder nach einem chirurgischen Eingriff
US8765377B2 (en) 2011-10-13 2014-07-01 Boston Heart Diagnostics Corporation Compositions and methods for treating and preventing coronary heart disease
WO2014034168A1 (ja) * 2012-08-30 2014-03-06 Hashida Seiichi 早期腎障害の評価マーカーとその測定方法
US20140120559A1 (en) 2012-10-26 2014-05-01 Boston Heart Diagnostics Corporation Diabetes panel
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
JP6512590B2 (ja) * 2014-08-25 2019-05-15 メカノジェニック株式会社 メタボリックシンドローム発症の危険性の予測方法
US9739790B2 (en) 2014-11-17 2017-08-22 Boston Heart Diagnostic Corporation Cardiovascular disease risk assessment
CN108027371B (zh) * 2015-07-07 2020-08-18 思齐乐 流感效力试验
EP3929584B1 (de) 2016-09-06 2024-08-14 Fujirebio Inc. Verfahren zur messung von thyreoglobulin
JP6999561B2 (ja) 2016-09-13 2022-02-10 富士レビオ株式会社 心筋トロポニンの測定方法及び測定試薬
EP3978921A4 (de) 2019-05-24 2023-05-24 Fujirebio Inc. Verfahren und system zur messung von thyreoglobulin
JP7494199B2 (ja) 2019-09-27 2024-06-03 富士レビオ株式会社 Ｂ型肝炎ウイルスコア関連抗原のイムノアッセイ及びそのためのキット
CN111239421A (zh) * 2020-02-19 2020-06-05 安徽大千生物工程有限公司 一种定量检测脂联素adpn的胶乳增强免疫比浊试剂盒及其制备与应用方法
US20230160912A1 (en) 2020-03-31 2023-05-25 Fujirebio Inc. Method for immunoassay of amyloid beta in blood, and kit for same
CN111892907B (zh) * 2020-07-15 2021-11-02 广东省医疗器械研究所 一种白蛋白胶粘剂及其制备方法
CN117616277A (zh) 2021-08-06 2024-02-27 株式会社先端生命科学研究所 甲状腺球蛋白的免疫检测及用于其的试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
JP4424775B2 (ja) 1999-04-21 2010-03-03 大塚製薬株式会社 抗原蛋白質の検出方法
CN1281981A (zh) * 1999-07-26 2001-01-31 武汉埃克玛生物技术有限公司 血清低密度脂蛋白测定试剂
CN1111201C (zh) * 1999-11-04 2003-06-11 孙续国 低密度脂蛋白受体检测试剂及方法
JP4458622B2 (ja) 2000-05-26 2010-04-28 積水メディカル株式会社 免疫学的測定方法及び測定用試薬
JP4547696B2 (ja) 2001-06-07 2010-09-22 第一三共株式会社 肝硬変予防・治療剤
EP1426764B1 (de) * 2001-08-17 2011-03-30 Fujirebio, Inc. Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel

Also Published As

Publication number Publication date
CA2542824C (en) 2013-08-27
EP2071333A3 (de) 2009-07-08
US7608405B2 (en) 2009-10-27
KR20060132571A (ko) 2006-12-21
DE602004022575D1 (de) 2009-09-24
ATE439590T1 (de) 2009-08-15
JP4677545B2 (ja) 2011-04-27
US20090291461A1 (en) 2009-11-26
KR101206338B1 (ko) 2012-12-03
CA2542824A1 (en) 2005-04-28
EP2071333B1 (de) 2012-04-18
AU2004282754A1 (en) 2005-04-28
CN1867828A (zh) 2006-11-22
ES2383259T3 (es) 2012-06-19
US8039223B2 (en) 2011-10-18
CN1867828B (zh) 2010-09-29
ES2329582T3 (es) 2009-11-27
JPWO2005038457A1 (ja) 2007-01-18
AU2004282754B9 (en) 2009-12-10
EP2071333A2 (de) 2009-06-17
WO2005038457A1 (ja) 2005-04-28
US20070042424A1 (en) 2007-02-22
EP1681566A4 (de) 2007-05-02
AU2004282754B2 (en) 2009-11-12
MXPA06004235A (es) 2007-02-14
EP1681566A1 (de) 2006-07-19
EP1681566B1 (de) 2009-08-12

Similar Documents

Publication Publication Date Title
ATE554385T1 (de) Verfahren zur selektiven untersuchung von adiponectin-multimeren
DE69638004D1 (de) Protein-färbung mittels merocyanin farbstoffe
ATE509120T1 (de) Fusionsproteine zur detektion von analyten
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
Manabe et al. Identification map of human plasma proteins: Micro two‐dimensional electrophoresis followed by multiple immunoreplica technique
ATE516304T1 (de) Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden
EP1623227A4 (de) Proteine, sensoren und verfahren zur charakterisierung von analyten damit
DE69841037D1 (de) Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.
MX9200709A (es) Activacion mejorada de proteinas recombinadas. activacion mejorada de proteinas recombinadas.
ATE474855T1 (de) Polyklonaler-monoklonaler-elisa-assay zum nachweis von n-terminalem probnp
SE8802944L (sv) Material foer lapptestning
DK0946873T3 (da) Fremgangsmåde til diagnose af allergisk bronkopulmonal aspergillose
ATE322688T1 (de) Verfahren zur bestimmung der nitrosylierung von proteinen
Crettaz et al. Proteomics of methylene blue photo‐treated plasma before and after removal of the dye by an absorbent filter
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
DE60203599D1 (de) Methode zur Inaktivierung von TSE
IL162568A0 (en) fluorescent protein from aequorea coerulscens and uses thereof
CA2471026A1 (en) Method of electrophoresing protein
BRPI0406265B8 (pt) método para análise por eletroforese capilar, método para pesquisa e tipagem de proteínas monoclonais, método de preparação de anticorpos modificados sobrecarregados negativamente e kit para detecção e tipagem de proteínas monoclonais
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
EP1560025A3 (de) Marker spezifisch für Diabetes
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
Manabe et al. Identification of bovine fetal and adult serum/plasma proteins by two‐dimensional electrophoresis and immunochemical staining
Kustos et al. Effect of iron restriction on outer membrane protein composition of Pseudomonas strains studied by conventional and microchip electrophoresis